Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02013219
Title A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | ESP

Facility Status City State Zip Country Details
UC Irvine Medical Center Orange California 92868 United States Details
Yale University School Of Medicine New Haven Connecticut 06510 United States Details
Florida Hospital Cancer Inst Orlando Florida 32804 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Massachusetts General Hospital;Hematology/ Oncology Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Med Ctr; Neurology/MS Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Cancer Center; Department of Oncology Detroit Michigan 48201 United States Details
Memorial Sloan Kettering - Basking Ridge New York New York 10065 United States Details
Case Western Reserve University; Medicine-Hematology and Oncology Cleveland Ohio 44106 United States Details
Institut Gustave Roussy Villejuif 94805 France Details
The Chinese University of Hong Kong Shatin 123456 Hong Kong Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
START Madrid. Centro Integral Oncologico Clara Campal; CIOCC Madrid 28050 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
Queen Mary University of London London EC1M 6BQ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field